The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLC
Phase 1 / Phase 2 · 1 site
Search the registry
2,585 studies found
Phase 1 / Phase 2 · 1 site
Phase 1 / Phase 2 · 13 sites
Phase 2 · 9 sites
Phase 1 · 5 sites
Phase 2 · 1 site
Potential match only. Final eligibility is determined by the study team.